5CmTERT-Ad showed significantly higher cancer cell-killing efficacy than mTERT promoter-driven oncolytic adenovirus (mTERT-Ad) did, indicating that insertion of five additional c-Myc-binding sites greatly augmented transcriptional activity of the mTERT promoter (Supplementary Fig. 2b). Here, MYC is linked to cancer.